EMR (NYSE: EMR) shareholder plans Rule 144 sale of 2,876 shares

Rhea-AI Filing Summary

A holder of common stock in an issuer associated with ticker EMR has filed a Rule 144 notice to sell 2,876 shares. The proposed sale, through Stifel Nicolaus & Company Inc. on the NYSE around 02/05/2026, has an aggregate market value of 438,590.00.

The filing notes that there are 562,000,000 shares of this class outstanding. The 2,876 shares were acquired on 02/04/2026 via restricted stock units from the issuer, with 2,876 securities tied to a 12/10/2025 cash dividend payment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	2876	438590.00	562000000	02/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/04/2026	Restricted Stock Units	Issuer			2876	12/10/2025	Cash Dividend

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EMR Rule 144 filing disclose about planned share sales?

The filing discloses a planned Rule 144 sale of 2,876 common shares associated with ticker EMR. These shares are proposed to be sold on the NYSE through Stifel Nicolaus & Company Inc. with an aggregate market value of 438,590.00.

How many EMR shares are outstanding compared with the Rule 144 sale amount?

The document states there are 562,000,000 common shares outstanding for the issuer tied to ticker EMR. The planned Rule 144 sale covers 2,876 shares, which is a very small fraction of the total outstanding share count disclosed.

When were the EMR shares in this Rule 144 notice acquired and how?

The 2,876 shares in the Rule 144 notice were acquired on 02/04/2026 as restricted stock units from the issuer. The table also links these securities to a 12/10/2025 cash dividend payment as the nature of payment for the acquisition.

Which broker will handle the EMR Rule 144 share sale and on what exchange?

The planned Rule 144 sale of 2,876 EMR shares will be handled by Stifel Nicolaus & Company Inc., located in St. Louis, Missouri. The filing specifies that the shares are expected to be sold on the NYSE securities exchange.

What is the approximate timing and market value of the EMR Rule 144 sale?

The filer indicates an approximate sale date of 02/05/2026 for the 2,876 EMR shares. The aggregate market value associated with this planned transaction is listed as 438,590.00, based on the information provided in the Rule 144 securities information table.